recombinant insulin lisargine (Hefei Tianmai Biotechnology)

N/A

Report date: 2025/03/20 09:34:06

Base Information

Drug Namerecombinant insulin lisargine (Hefei Tianmai Biotechnology)
Drug Alias Namerecombinant insulin laijing (Hefei Tianmai Biotechnology)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInsulin ligandInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHefei Tianmai Biotechnology Development Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHefei Tianmai Biotechnology Development Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A